Past Events

Fresh off the heels of last Tuesday's successful Weill Cornell Medicine Cores Day, we are excited to share the next installment of BioVenture eLab’s and Ford Center Incubator’s Core Facilities Series. This episode will focus on physician-scientists and an essential resource for innovation testing and cross-discipline training.

Featured Guest:

Kevin Ching, M.D.

• Medical Director, Weill Cornell Medicine and NewYork-Presbyterian Simulation Center
• Assistant Attending Physician
• Associate Professor, Emergency Medicine & Pediatrics

The WCM and NYP Simulation Center is a leader in interprofessional, experiential healthcare education. As a comprehensive and integrated partnership between the Departments of Emergency Medicine, Internal Medicine, OB-GYN, and Pediatrics, this core facility strives to reinvent how knowledge is shared through simulation-based education. The center creates and develops innovations in interprofessional education, collaborative research and patient safety.

Discover more about its experiential learning opportunities for: 

• Patient safety initiatives
• Interprofessional teamwork behaviors
• Advanced life support skills
• Advanced airway procedures
• Trauma resuscitation skills
• ACGME core competencies

Hosts

Loren A. Busby, CFA, Director, Weill Cornell Medicine BioVenture eLab
Carlo Yuvienco, PhD, Director, Ford Center Incubator @ The Rockefeller University

 Register here. 

In the past, obtaining an issued patent from the U.S. Patent and Trademark Office usually meant wrangling with a patent examiner over the pillars of patentability, novelty and obviousness. However, the Supreme Court's 2023 decision in Amgen v. Sanofi thrust another lesser-known condition, the enablement requirement, to the forefront. Citing the enablement requirement, the Court curtailed the breadth of the Amgen's patent claims, stating that the specification did not support their broad claims to classes of molecules. In the aftermath, inventors, patent holders and practitioners have been left scrambling to figure out how this new interpretation of enablement affects them.

Join us for a webinar with Yvonne Shyntum, Partner at PABST Patent Group, as she walks through the Court's interpretation of enablement and practical strategies for complying with enablement. Dr. Shyntum holds a Ph.D. in Molecular and Systems Pharmacology from Emory University and a J.D. from Georgia State University. She represents clients in the biotechnology and pharmaceutical areas and regularly presents on intellectual property topics. 

Register here. 

Applications are open for the Summer 2025 Prototyping Hardware Accelerator at Rev: Ithaca Startup Works! 

Over 10 weeks, Rev’s in-person Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Want to learn more? Register to attend an upcoming virtual information session. Questions? Contact rev@revithaca.com.

In this virtual course (held February 10 - March 12), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.

Apply here. Questions? Contact icorps@cornell.edu.